Rafael Muniz Selected Research

Insulin (Novolin)

1/2020	Efficacy and safety of MYL-1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study.
1/2019	Efficacy and safety of MYL-1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rafael Muniz Research Topics

Disease

16	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2013 - 01/2003
3	Rheumatoid Arthritis 03/2021 - 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Necrosis 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2018
1	Chromosome Aberrations (Chromosome Abnormalities) 06/2009
1	Abdominal Pain (Pain, Abdominal) 01/2008
1	Headache (Headaches) 01/2008

Drug/Important Bio-Agent (IBA)

11	Dexmethylphenidate Hydrochloride FDA LinkGeneric 07/2013 - 06/2006
9	Methylphenidate (Ritalin)FDA LinkGeneric 07/2013 - 01/2003
3	Adalimumab (Humira)FDA Link 03/2021 - 01/2020
3	Biosimilar PharmaceuticalsIBA 03/2021 - 01/2020
2	FKB327IBA 11/2020 - 01/2020
2	Insulin (Novolin)FDA Link 01/2020 - 01/2019
2	MYL-1501DIBA 01/2020 - 01/2019
2	Insulin Glargine (Lantus)FDA Link 01/2020 - 01/2019
2	Therapeutic UsesIBA 01/2008 - 12/2006
1	Antirheumatic Agents (DMARD)IBA 03/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2018
1	Amphetamine (Amfetamine)FDA LinkGeneric 09/2010
1	SaltsIBA 09/2010
1	ZeinIBA 06/2009

Therapy/Procedure

1	Therapeutics 01/2018